Only two of them, DR4 and DR5, harbor the death domain (DD), a stretch of ~90 amino acids (aa), required and sufficient to activate the apoptotic machinery; they consequently represent promising targets for cancer treatment. The gene discussed is TNFRSF10A; the disease is cancer.